XtalPi Holdings Limited (QNTPF)
OTCMKTS · Delayed Price · Currency is USD
1.000
0.00 (0.00%)
At close: Apr 25, 2025

XtalPi Holdings Company Description

XtalPi Holdings Limited, an investment holding company, engages in the provision of robotics and drug discovery solutions in Mainland China, the United States, and internationally.

The company offers XMolGen, an AI small molecule drug discovery smart computation platform; XtalFold, an antibody-antigen complex structure prediction platform which predicts the antibody-antigen complex structure and identifies key interaction sites; and Xtalgazer, a new generation of drug crystallization research and development platform which predict the physicochemical properties, crystal structure, and stability relationship of compound molecules based on hundreds of thousands of crystallization data accumulated by physical models combined with AI algorithms.

It also provides automated chemical synthesis services; and Al+robotics laboratory intelligent automation solutions.

In addition, the company offers PatSight, an AI-powered patent data extraction tool, automates the extraction of key data from up to 12 patents delivering editable formats as CSV or SDF files with SMILES; XFEP, a tool used to predict affinity prediction between candidate compounds and their biological targets.

Further, it provides drug discovery solutions comprising hit discovery, hit or lead optimization, and biology capabilities service; discovery chemistry solutions, including automation-aided chemical synthesis and focused library services; and experimental solid-state research and development, solid-state chemistry computational solutions, and crystal structure determination.

The company was formerly known as QuantumPharm Inc. and changed its name to XtalPi Holdings Limited in December 2024.

XtalPi Holdings Limited was founded in 2015 and is headquartered in Shenzhen, China.

XtalPi Holdings Limited
Country Cayman Islands
Founded 2015
Industry Commercial Physical and Biological Research
Employees 809
CEO Jian Ma

Contact Details

Address:
Second Phase of the International
Shenzhen
China
Phone 86 755 8190 1777
Website xtalpi.com

Stock Details

Ticker Symbol QNTPF
Exchange OTCMKTS
Fiscal Year January - December
Reporting Currency CNY
SIC Code 8731

Key Executives

Name Position
Dr. Jian Ma Ph.D. Chief Executive Officer and Executive Director
Dr. Shuhao Wen Chairman
Dr. Lipeng Lai Chief Innovation Officer and Executive Director
Dr. Yide Jiang Chief Strategic Officer and Executive Director
Man Hong Tam Chief Financial Officer
Dr. Peiyu Zhang Chief Scientific Officer
Sau Ling Chan ACIS, ACS(PE), FCIS, P.E. Joint Company Secretary
Shimei Liu Joint Company Secretary